Tags

Type your tag names separated by a space and hit enter

Specific celiac disease antibodies in children on a gluten-free diet.
Pediatrics. 2011 Sep; 128(3):547-52.Ped

Abstract

OBJECTIVE

Celiac disease (CD) is characterized by histologic alterations in small bowel biopsies. Circulating specific CD antibodies at the time of diagnosis and their disappearance after a gluten-free diet support the diagnosis of CD. We aimed to determine the behavior of the CD antibodies immunoglobulin A anti-tissue transglutaminase (anti-TG2) and immunoglobulin A endomysium (EMA) in children with CD after starting a gluten-free diet.

METHODS

This was a retrospective multicenter study in the Netherlands between 2001 and 2009. Inclusion criteria were all newly diagnosed patients with CD younger than 19 years who had at least 1 anti-TG2 and/or EMA measurement before and after starting a gluten-free diet. Eight different anti-TG2 kits were used with substrates of guinea pig TG2 in 1 (Sigma) and 7 human-recombinant TG2: Varelisa and EliA Celikey Phadia-GmbH; Orgentec Diagnostica-GmbH; Diarect AG; Roboscreen GmbH; Aeskulisa Diagnostics; Binding Site Ltd. EMA was analyzed with indirect immunofluorescence tests. Statistical analyses were performed by using mixed-model repeated measurements and survival analysis.

RESULTS

There were 129 children with CD included (mean age: 5.6 years; SD ± 4.2). The mean concentration of anti-TG2 decreased significantly within 3 months after starting a gluten-free diet (P < .0001). The cumulative percentage of children who became negative for EMA after ½, 1, 1½, and 2 years was 31%, 60%, 74%, and 87%, respectively. For anti-TG2, a comparable trend was shown: 35%, 55%, 64%, and 78%, respectively.

CONCLUSIONS

Doctors taking care of children with CD should be aware that the mean concentration of anti-TG2 will show a 74% decrease (95% confidence interval: 69%-79%) after 3 months of gluten-free diet, and ∼80% of the children will be sero-negative for EMA and anti-TG2 after 2 years of the diet.

Authors+Show Affiliations

Department of Pediatric Gastroenterology, Leiden University Medical Centre, Leiden, Netherlands. c.e.hogen_esch@lumc.nlNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article
Multicenter Study

Language

eng

PubMed ID

21859913

Citation

Hogen Esch, Caroline E., et al. "Specific Celiac Disease Antibodies in Children On a Gluten-free Diet." Pediatrics, vol. 128, no. 3, 2011, pp. 547-52.
Hogen Esch CE, Wolters VM, Gerritsen SA, et al. Specific celiac disease antibodies in children on a gluten-free diet. Pediatrics. 2011;128(3):547-52.
Hogen Esch, C. E., Wolters, V. M., Gerritsen, S. A., Putter, H., von Blomberg, B. M., van Hoogstraten, I. M., Houwen, R. H., van der Lely, N., & Mearin, M. L. (2011). Specific celiac disease antibodies in children on a gluten-free diet. Pediatrics, 128(3), 547-52. https://doi.org/10.1542/peds.2010-3762
Hogen Esch CE, et al. Specific Celiac Disease Antibodies in Children On a Gluten-free Diet. Pediatrics. 2011;128(3):547-52. PubMed PMID: 21859913.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Specific celiac disease antibodies in children on a gluten-free diet. AU - Hogen Esch,Caroline E, AU - Wolters,Victorien M, AU - Gerritsen,Susan A M, AU - Putter,Hein, AU - von Blomberg,B Mary, AU - van Hoogstraten,Ingrid M W, AU - Houwen,Roderick H J, AU - van der Lely,Nico, AU - Mearin,M Luisa, Y1 - 2011/08/22/ PY - 2011/8/24/entrez PY - 2011/8/24/pubmed PY - 2012/4/24/medline SP - 547 EP - 52 JF - Pediatrics JO - Pediatrics VL - 128 IS - 3 N2 - OBJECTIVE: Celiac disease (CD) is characterized by histologic alterations in small bowel biopsies. Circulating specific CD antibodies at the time of diagnosis and their disappearance after a gluten-free diet support the diagnosis of CD. We aimed to determine the behavior of the CD antibodies immunoglobulin A anti-tissue transglutaminase (anti-TG2) and immunoglobulin A endomysium (EMA) in children with CD after starting a gluten-free diet. METHODS: This was a retrospective multicenter study in the Netherlands between 2001 and 2009. Inclusion criteria were all newly diagnosed patients with CD younger than 19 years who had at least 1 anti-TG2 and/or EMA measurement before and after starting a gluten-free diet. Eight different anti-TG2 kits were used with substrates of guinea pig TG2 in 1 (Sigma) and 7 human-recombinant TG2: Varelisa and EliA Celikey Phadia-GmbH; Orgentec Diagnostica-GmbH; Diarect AG; Roboscreen GmbH; Aeskulisa Diagnostics; Binding Site Ltd. EMA was analyzed with indirect immunofluorescence tests. Statistical analyses were performed by using mixed-model repeated measurements and survival analysis. RESULTS: There were 129 children with CD included (mean age: 5.6 years; SD ± 4.2). The mean concentration of anti-TG2 decreased significantly within 3 months after starting a gluten-free diet (P < .0001). The cumulative percentage of children who became negative for EMA after ½, 1, 1½, and 2 years was 31%, 60%, 74%, and 87%, respectively. For anti-TG2, a comparable trend was shown: 35%, 55%, 64%, and 78%, respectively. CONCLUSIONS: Doctors taking care of children with CD should be aware that the mean concentration of anti-TG2 will show a 74% decrease (95% confidence interval: 69%-79%) after 3 months of gluten-free diet, and ∼80% of the children will be sero-negative for EMA and anti-TG2 after 2 years of the diet. SN - 1098-4275 UR - https://www.unboundmedicine.com/medline/citation/21859913/Specific_celiac_disease_antibodies_in_children_on_a_gluten_free_diet_ L2 - http://pediatrics.aappublications.org/cgi/pmidlookup?view=long&amp;pmid=21859913 DB - PRIME DP - Unbound Medicine ER -